Second Mondays, noon - 1 p.m.
The purpose of this ECHO program is to discuss your complex cases as they arise, share and learn emerging best practices in the areas of addiction medicine and pain management (through conversation, not didactics), and foster community among a group of Oregon clinicians and other healthcare professionals who have dedicated considerable time to improving their knowledge and skills in these topic areas.
Participation will be limited to healthcare professionals who either have:
*Accreditation: Oregon Health & Science University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit: OHSU School of Medicine designates this live activity for a maximum of 10.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MOC Credit: Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, Addiction Medicine Curbsides and Conversation has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:
This program is registered for MOC part II through the American Board of Internal Medicine (ABIM).
In accordance with the requirements of the ACCME's Standards for Integrity and independence in Accredited Continuing Education, each instructor and member of the planning committee has been asked to disclose any relevant financial relationships with ineligible companies (defined as: any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients). All of the relevant financial relationships listed for these individuals have been mitigated.
Program Planners: Daniel Hoover, MD, and Jonathan Robbins, MD, have nothing to disclose
Program Presenter: Jonathan Robbins, MD, has nothing to disclose
|1 - Session 1||9/13/2021|
|2 - Session 2||10/11/2021|
|3 - Session 3||11/8/2021|
|4 - Session 4||12/13/2021|
|5 - Session 5||1/10/2022|
|6 - Session 6||2/14/2022|
|7 - Session 7||3/14/2022|
|8 - Session 8||4/11/2022|
|9 - Session 9||5/9/2022|
|10 - Session 10||6/13/2022|